CLASS III ONGOING Drug recall · Reported 29 Oct 2025 · FDA Enforcement Report

Cetirizine Hydrochloride Tablets USP 10 mg recalled by JB Chemicals and

JB Chemicals and Pharmaceuticals is recalling Cetirizine Hydrochloride Tablets USP 10 mg, distributed nationwide in the US. The recall was initiated on 12 Sep 2025 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # PY925014A; Exp. 1/31/2028
NDC16571-402
Quantity recalled9936 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0032-2026
FDA event ID
97573
Recalling firm
JB Chemicals and Pharmaceuticals, Mumbai
Manufacturer
Rising Pharma Holdings, Inc.
Classification
Class III
Status
Ongoing
Recall initiated
12 Sep 2025
FDA classified
17 Oct 2025
Reported
29 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

12 Sep 2025Recall initiated by company
17 Oct 2025Classified by FDA+35 days
29 Oct 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Tablet/Capsules Imprinted with Wrong ID

Product as listed by the FDA

Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10.

Where it was distributed

U.S. Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Tablet/Capsules Imprinted with Wrong ID

Which lots are affected?

Lot # PY925014A; Exp. 1/31/2028

Where was it sold?

U.S. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 97573
ReportedClassRecallCompanyReasonWhere
CLASS IIICetirizine Hydrochloride Tablets USP 10 mg recalled by JB Chemicals andCetirizine HydrochlorideJB Chemicals and PharmaceuticalsOtherNationwide

More recalls from JB Chemicals and Pharmaceuticals

All 4

Other Cetirizine recalls

All 18